This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van Buren, M. Articles by Koomans, H. A. Search for Related Content PubMed PubMed Citation Articles by van Buren, M. Articles by Koomans, H. A.

Hypertension, Vol 22, 728-734, Copyright © 1993 by American Heart Association

ARTICLES

Natriuretic and hypotensive effect of adenosine-1 blockade in essential hypertension

M van Buren, JA Bijlsma, P Boer, HJ van Rijn and HA Koomans
Department of Nephrology and Hypertension, University Hospital Utrecht, The Netherlands.

We studied the effects of a single dose (100 mg orally) and repeated administration (100 mg o.d. for 7 days) of FK453, a novel adenosine-1 receptor antagonist, on renal sodium handling and blood pressure in eight patients with essential hypertension. Within 60 minutes after administration of FK453, sodium excretion increased threefold. This occurred in the absence of a change in renal hemodynamics, assessed from inulin and para-aminohippurate clearance, and was accompanied by increased fractional excretion of lithium, phosphate, and uric acid and by increased excretion of calcium and magnesium. Maximal free water clearance data showed an increase in maximal urine flow and distal delivery term and a decrease in the diluting segment reabsorption term. FK453 also decreased blood pressure and increased heart rate, but this did not occur until about 3 hours after ingestion, that is, when the natriuresis was already over. The natriuretic effect of FK453 was short- lasting, and continued use of FK453 was in fact accompanied by some net sodium retention. Blood pressure on the seventh day before FK453 treatment was not different from blood pressure before administration of the first dose of FK453. Again an acute natriuretic response followed, although less than after the first dose. Changes in intrarenal sodium handling parameters, blood pressure, and heart rate were similar to those seen after the first dose. The natriuretic and hypotensive effects of FK453 indicate that adenosine-1 receptor activity plays a role in the regulation of blood pressure and renal sodium handling in patients with essential hypertension.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. Kulick, C. Panico, P. Gill, and W. J. Welch Low salt intake increases adenosine type 1 receptor expression and function in the rat proximal tubule Am J Physiol Renal Physiol, July 1, 2008; 295(1): F37 - F41. [Abstract] [Full Text] [PDF]

				V. Vallon, C. Miracle, and S. Thomson Adenosine and kidney function: Potential implications in patients with heart failure Eur J Heart Fail, February 1, 2008; 10(2): 176 - 187. [Abstract] [Full Text] [PDF]

				V. Vallon, B. Muhlbauer, and H. Osswald Adenosine and kidney function. Physiol Rev, July 1, 2006; 86(3): 901 - 940. [Abstract] [Full Text] [PDF]

				X. Zhou and C. K. Kost Jr. Adenosine A1 Receptor Antagonist Blunts Urinary Potassium Excretion, but Not Renal Hemodynamic Effects, Induced by Carbonic Anhydrase Inhibitor in Rats J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 530 - 538. [Abstract] [Full Text] [PDF]

				T. Rieg, H. Steigele, J. Schnermann, K. Richter, H. Osswald, and V. Vallon Requirement of Intact Adenosine A1 Receptors for the Diuretic and Natriuretic Action of the Methylxanthines Theophylline and Caffeine J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 403 - 409. [Abstract] [Full Text] [PDF]

				M. Bak and K. Thomsen Effects of the adenosine A1 receptor inhibitor FK 838 on proximal tubular fluid output in rats Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1077 - 1082. [Abstract] [Full Text] [PDF]

				E. K. Jackson and R. K. Dubey Role of the extracellular cAMP-adenosine pathway in renal physiology Am J Physiol Renal Physiol, October 1, 2001; 281(4): F597 - F612. [Abstract] [Full Text] [PDF]

				C. K. Kost Jr., W. A. Herzer, B. R. Rominski, Z. Mi, and E. K. Jackson Diuretic Response to Adenosine A1 Receptor Blockade in Normotensive and Spontaneously Hypertensive Rats: Role of Pertussis Toxin-Sensitive G-Proteins J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 752 - 760. [Abstract] [Full Text]

				C. S. WILCOX, W. J. WELCH, G. F. SCHREINER, and L. BELARDINELLI Natriuretic and Diuretic Actions of a Highly Selective Adenosine A1 Receptor Antagonist J. Am. Soc. Nephrol., April 1, 1999; 10(4): 714 - 720. [Abstract] [Full Text]

				M. Gellai, G. F. Schreiner, R. R. Ruffolo Jr., T. Fletcher, R. DeWolf, and D. P. Brooks CVT-124, a Novel Adenosine A1 Receptor Antagonist with Unique Diuretic Activity J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1191 - 1196. [Abstract] [Full Text]

				V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF]